FIELD: medicine.
SUBSTANCE: there are presented a polynucleotide coding an antibody, an expression vector, a host cell, compositions containing the antibody, and also a method for preparing the antibody and methods for using the antibody.
EFFECT: invention may be used for preparing therapeutic and diagnostic agents to be used for the purpose of detecting the pathological conditions associated with expression or activity of ephrine B2 ligand pathways.
27 cl, 10 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-EphB4 ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | 2007 |
|
RU2450020C2 |
DLL4 ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2007 |
|
RU2415869C2 |
ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
ANTIBODIES AGAINST FGFR3 AND METHODS OF THEIR APPLICATION | 2010 |
|
RU2568066C2 |
ANTI-BV8 ANTIBODIES AND USING THEM | 2010 |
|
RU2559542C2 |
ANTIBODIES AGAINST AXL AND THEIR APPLICATION | 2011 |
|
RU2577986C2 |
AFUCOSYLATED FGFR2IIIB FIBROBLAST GROWTH FACTOR RECEPTOR | 2014 |
|
RU2698061C2 |
AFUCOSYLATED FIBROBLAST GROWTH FACTOR FGFR2IIIB RECEPTOR | 2014 |
|
RU2740714C2 |
NRR Notch1 ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2008 |
|
RU2476443C2 |
Authors
Dates
2012-05-20—Published
2007-01-19—Filed